Diabetic neuropathy is a clinical condition that can have a significant impact on quality of life,
presenting as numbness, tingling, and burning in the extremities. Current treatment options …

The present invention relates to, inter alia, pharmaceutical compositions comprising EPA
and one or more cardiovascular agents, and to therapeutic methods for treating various …

Objective: To systematically assess benefits and harm of non-pharmacologic interventions
for diabetic peripheral neuropathy (DPN) symptoms. Methods: MEDLINE, Embase, and the …

Peripheral neuropathy (PN) is a common disease affecting about 5% of the general
population after the age of 50. Causes of PN are numerous and include genetic, diabetes …

В обзоре рассматриваются медико-биологические аспекты свободнорадикальной
теории, клинический опыт применения антиоксидантных средств, перспективы …

The increasing prevalence of diabetes mellitus world-wide is an issue of major socio-
economic concern. Scientific interest in plant-derived medicine is steadily rising, yet there is …

In various embodiments, the present invention provides methods of treating and/or
preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy …

Opinion statement No current disease-modifying treatments have been shown definitively in
randomized clinical trials to reduce or reverse diabetic sensory polyneuropathy (DSP). It is …

Background The most common of the neuropathies associated with diabetes mellitus,
diabetic sensorimotor polyneuropathy (DSPN) is a syndrome of diffuse, length-dependent …

US8563608B2 - Methods for lowering triglycerides without raising LDL-C levels in a subject
on concomitant statin therapy - Google Patents US8563608B2 - Methods for lowering …